Published in Am J Public Health on May 01, 1993
Clarification on the coding of hip fractures. Am J Public Health (1994) 0.75
Contraindicated use of cisapride: impact of food and drug administration regulatory action. JAMA (2000) 3.81
Foamy virus particle formation. J Virol (1998) 2.22
Isoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies. Am Rev Respir Dis (1979) 2.15
Myopathy and rhabdomyolysis associated with lovastatin-gemfibrozil combination therapy. JAMA (1990) 2.05
Cisapride and fatal arrhythmia. N Engl J Med (1996) 2.00
Incidence of lactic acidosis in metformin users. Diabetes Care (1999) 1.81
Context dependence of different modules for posttranscriptional enhancement of gene expression from retroviral vectors. Mol Ther (2000) 1.71
Coronary disease severity and functional impairment: how strong is the relation? J Am Geriatr Soc (1996) 1.66
Outpatient use of prescription sedative-hypnotic drugs in the United States, 1970 through 1989. Arch Intern Med (1991) 1.62
Sex hormone levels in serum in relation to the development of breast cancer. Am J Epidemiol (1987) 1.55
Design of 5' untranslated sequences in retroviral vectors developed for medical use. J Virol (1999) 1.48
Overcoming promoter competition in packaging cells improves production of self-inactivating retroviral vectors. Gene Ther (2006) 1.44
Noncontraceptive estrogens and progestins: use patterns over time. Obstet Gynecol (1985) 1.42
Trends in use of oral hypoglycemic agents 1964-1986. Diabetes Care (1989) 1.42
Long-term effects of otitis media: a ten-year cohort study of Alaskan Eskimo children. Pediatrics (1973) 1.40
Woodchuck hepatitis virus post-transcriptional regulatory element deleted from X protein and promoter sequences enhances retroviral vector titer and expression. Gene Ther (2006) 1.39
Leukemia induction after a single retroviral vector insertion in Evi1 or Prdm16. Leukemia (2008) 1.35
Utilization of nonsteroidal antiinflammatory drugs. Arthritis Rheum (1985) 1.32
Creutzfeldt-Jakob disease in pituitary growth hormone recipients in the United States. JAMA (1991) 1.28
Functional status in coronary artery disease: a one-year prospective study of the role of anxiety and depression. Am J Med (1997) 1.27
B cell subsets and differential responses to mitogens. Immunol Rev (1982) 1.26
Cell surface antigens expressed by subsets of pre-B cells and B cells. J Immunol (1984) 1.26
Prescribing of noncontraceptive estrogens and progestins in the United States, 1974-86. Am J Public Health (1988) 1.24
Pois(s)on--it's a question of dose... Gene Ther (2004) 1.23
Self-inactivating retroviral vectors with improved RNA processing. Gene Ther (2004) 1.23
Stem cell clonality and genotoxicity in hematopoietic cells: gene activation side effects should be avoidable. Semin Hematol (2004) 1.22
Drug use in the United States in 1981. JAMA (1984) 1.18
A first-generation packaging cell line for Epstein-Barr virus-derived vectors. Proc Natl Acad Sci U S A (1999) 1.16
Benign intracranial hypertension in children with growth hormone deficiency treated with growth hormone. J Pediatr (1995) 1.16
Lymphoid reconstitution of the human fetal thymus in SCID mice with CD34+ precursor cells. J Exp Med (1991) 1.16
The impact of the addition of naloxone on the use and abuse of pentazocine. Public Health Rep (1987) 1.13
Neuropsychological and neurophysiologic effects of carbamazepine and levetiracetam. Neurology (2007) 1.11
Transgene optimization significantly improves SIN vector titers, gp91phox expression and reconstitution of superoxide production in X-CGD cells. Gene Ther (2008) 1.11
CD34 splice variant: an attractive marker for selection of gene-modified cells. Mol Ther (2000) 1.10
Influence of multiplicity of infection and protein stability on retroviral vector-mediated gene expression in hematopoietic cells. Gene Ther (2001) 1.08
Retroviral vector-mediated expression of HoxB4 in hematopoietic cells using a novel coexpression strategy. Gene Ther (2001) 1.07
Retroviral vectors pseudotyped with lymphocytic choriomeningitis virus. J Virol (1999) 1.05
Isotretinoin and pregnancy. J Am Acad Dermatol (1984) 1.03
A novel NK-related mouse homeobox gene: expression in central and peripheral nervous structures during embryonic development. Dev Biol (1994) 1.01
A study of a possible association between breast cancer and gallbladder disease. Am J Epidemiol (1986) 1.00
Remarkable leukemogenic potency and quality of a constitutively active neurotrophin receptor, deltaTrkA. Leukemia (2007) 0.99
Pregnancy outcomes after first-trimester vaginitis drug therapy. Obstet Gynecol (1987) 0.98
Spontaneous adverse reaction reporting in the elderly. Lancet (1988) 0.98
EVI-1 modulates leukemogenic potential and apoptosis sensitivity in human acute lymphoblastic leukemia. Leukemia (2012) 0.97
Retroviral vector performance in defined chromosomal Loci of modular packaging cell lines. Hum Gene Ther (2010) 0.97
Thy-1-expressing CD34+ human cells express multiple hematopoietic potentialities in vitro and in SCID-hu mice. Nouv Rev Fr Hematol (1993) 0.96
Epidermal growth factor improves lentivirus vector gene transfer into primary mouse hepatocytes. Gene Ther (2011) 0.94
Spinal and epidural hematoma and low-molecular-weight heparin. N Engl J Med (1998) 0.94
CTF/NF1 transcription factors act as potent genetic insulators for integrating gene transfer vectors. Gene Ther (2011) 0.93
FMEV vectors: both retroviral long terminal repeat and leader are important for high expression in transduced hematopoietic cells. Gene Ther (1998) 0.93
A new PG13-based packaging cell line for stable production of clinical-grade self-inactivating gamma-retroviral vectors using targeted integration. Gene Ther (2009) 0.93
Mechanisms controlling titer and expression of bidirectional lentiviral and gammaretroviral vectors. Gene Ther (2009) 0.93
Drug use and expenditures in 1982. JAMA (1985) 0.92
High-dose multidrug resistance in primary human hematopoietic progenitor cells transduced with optimized retroviral vectors. Blood (1996) 0.92
Dominant selection of hematopoietic progenitor cells with retroviral MDR1 co-expression vectors. Hum Gene Ther (1998) 0.92
Variegation of retroviral vector gene expression in myeloid cells. Gene Ther (2000) 0.92
Scale-up and manufacturing of clinical-grade self-inactivating γ-retroviral vectors by transient transfection. Gene Ther (2011) 0.92
Towards hematopoietic stem cell-mediated protection against infection with human immunodeficiency virus. Gene Ther (2006) 0.91
Analysis of candidate human blood stem cells in "humanized" immune-deficiency SCID mice. Leukemia (1993) 0.91
A novel 'sort-suicide' fusion gene vector for T cell manipulation. Gene Ther (2002) 0.90
Activation of Evi1 inhibits cell cycle progression and differentiation of hematopoietic progenitor cells. Leukemia (2012) 0.87
Correction of murine Rag1 deficiency by self-inactivating lentiviral vector-mediated gene transfer. Leukemia (2011) 0.87
Depression and suicide in patients treated with isotretinoin. N Engl J Med (2001) 0.87
Retroviral transfer of MRP1 and gamma-glutamyl cysteine synthetase modulates cell sensitivity to L-buthionine-S,R-sulphoximine (BSO): new rationale for the use of BSO in cancer therapy. Eur J Cancer (2003) 0.86
Acceleration of hematopoietic reconstitution with a synthetic cytokine (SC-55494) after radiation-induced bone marrow aplasia. Blood (1996) 0.86
B-cell-specific transgene expression using a self-inactivating retroviral vector with human CD19 promoter and viral post-transcriptional regulatory element. Gene Ther (2004) 0.86
Stem cell self-renewal: lessons from bone marrow, gut and iPS toward clinical applications. Leukemia (2011) 0.85
Sedative-hypnotic drugs and the risk of hip fracture. J Clin Epidemiol (1996) 0.85
Progressive functional adaptation of segmental bowel graft from living related donor. Transplantation (2001) 0.85
Antiviral gene therapy. Handb Exp Pharmacol (2009) 0.85
Risk of leukemia after treatment with pituitary growth hormone. JAMA (1993) 0.85
Correction of B-cell development in Btk-deficient mice using lentiviral vectors with codon-optimized human BTK. Leukemia (2010) 0.84
Efficient in vivo regulation of cytidine deaminase expression in the haematopoietic system using a doxycycline-inducible lentiviral vector system. Gene Ther (2012) 0.84
Epidemic neonatal hyperbilirubinemia and use of a phenolic disinfectant detergent. Pediatrics (1978) 0.83
De novo lipogenesis in adipose tissue of lean and obese women: application of deuterated water and isotope ratio mass spectrometry. Int J Obes Relat Metab Disord (2000) 0.83
Effects of exposure to benzodiazepine during fetal life. Lancet (1992) 0.83
Antipsychotic drug use in the United States, 1976-1985. Arch Gen Psychiatry (1989) 0.82
Indices of drug misuse for prescription drugs. Int J Addict (1991) 0.82
Long-term results of Salter and Chiari hip osteotomies in developmental hip dysplasia. A survey of over 10 years follow-up with a new hip evaluation score. Arch Orthop Trauma Surg (1998) 0.82
Efficient expansion and gene transduction of mouse neural stem/progenitor cells on recombinant fibronectin. Neuroscience (2004) 0.81
Bicistronic retroviral vectors for combining myeloprotection with cell-surface marking. Gene Ther (1999) 0.81
Methodological limitations of the study "Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide". Arch Dermatol (2001) 0.81
Persisting multilineage transgene expression in the clonal progeny of a hematopoietic stem cell. Leukemia (2002) 0.81
Dietary triacylglycerol modulates sodium-dependent D-glucose transport, fluidity and fatty acid composition of rat small intestinal brush-border membrane. Biochim Biophys Acta (1989) 0.80
Improved post-transcriptional processing of an MDR1 retrovirus elevates expression of multidrug resistance in primary human hematopoietic cells. Gene Ther (2001) 0.80
Gynecomastia and breast cancer during finasteride therapy. N Engl J Med (1996) 0.80
Gene transfer into haemopoietic cells. Baillieres Clin Haematol (1997) 0.80
Rh hemolytic disease. Epidemiologic surveillance in the United States, 1968 to 1975. JAMA (1979) 0.80
Position paper: occupational performance: occupational therapy's definition of function. American Occupational Therapy Association. Am J Occup Ther (1996) 0.79
MDR1 gene expression in NOD/SCID repopulating cells after retroviral gene transfer under clinically relevant conditions. Mol Ther (2000) 0.79
Clinical scale production of an improved retroviral vector expressing the human multidrug resistance 1 gene (MDR1). Bone Marrow Transplant (2000) 0.78
Selection for Evi1 activation in myelomonocytic leukemia induced by hyperactive signaling through wild-type NRas. Oncogene (2012) 0.78
Removal of amalgam, glass-ionomer cement and compomer restorations: changes in cavity dimensions and duration of the procedure. Oper Dent (2002) 0.78
Novel bicistronic retroviral vector expressing gamma-glutamylcysteine synthetase and the multidrug resistance protein 1 (MRP1) protects cells from MRP1-effluxed drugs and alkylating agents. Hum Gene Ther (2001) 0.78
Retroviral vector-mediated gene expression in human CD34+CD38- cells expanded in vitro: cis elements of FMEV are superior to those of Mo-MuLV. Hum Gene Ther (2000) 0.77
Loss of CD38 antigen on CD34+CD38+ cells during short-term culture. Leukemia (2000) 0.77